enquiry@dsij.in |+91 9240904920
SENSEX315.20
73,895.740.43%

Zydus Lifesciences Ltd.

(Industry - Pharmaceuticals & Drugs)

₹1,202

22.00 (1.86%)

Today High/Low

L
H
₹1,183.35₹1,208.2

52 Week High/Low

L
H
₹860.55₹1,204

About Company

Zydus Lifesciences Limited develops, manufactures, markets and distributes pharmaceutical, consumer-health and medical-technology products. Its core pharmaceutical portfolio includes generics, branded generics, specialty formulations, biosimilars, vaccines and active pharmaceutical ingredients, alongside animal-health products. The Group serves regulated and emerging markets across India, the United States, Europe and other regions through 44 manufacturing facilities and 10 R&D centres. Its consumer business offers health and wellness products, while medical technologies include cardiovascular intervention devices and diagnostic solutions.

Market Cap.
₹1,19,899.96 Cr.
P/E Ratio
26.69
P/B Ratio
5.23
Current Price
₹1,202
Open
₹1,187.7
High
₹1,208.2
Prev Close
₹1,180
Quantity Traded
1,20,962
52 Week High
₹1,204
52 Week Low
₹860.55
Dividend Yield
0.08%
EBITDA Margin
29.15%
ROE
16.57%
Book Value
₹229.69
Face Value
₹1
MindshareMutual FundQuarterly ResultsInterviewsIPO AnalysisMultibaggerPenny StocksDividendBonus & Stock SplitSMEPersonal FinanceSwing Trading

If you want to stay updated with the Share Market News Today, keep a close watch on the Indian Stock Market Today with real time movements like Sensex Today Live and overall trends. Investors tracking IPO Allotment Status, IPO News Today, or the Latest IPO India can also follow daily updates along with BSE Share Price Live data. Whether you are learning How To Invest in Stock Market in India, preparing for a Market Crash Today, or searching for the Best Stocks to Buy in India, insights on Top Gainers Today India, Top Losers Today India, Trending Stocks India and Long Term Stocks India help in making informed investment decisions.

Stay informed, stay disciplined, and make smarter investment choices with timely and reliable market insights.